Viewing nowCombinationJanshiga S Tablets 10/100 mg (Dapagliflozin, Sitagliptin)
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Albogent Korea Co., Ltd.

MFDS item code 202300072 · Approved 2023.01.06 · Insurance code 652607180
Improvement of blood sugar control in type 2 diabetes
This medication is used to effectively improve blood sugar control in patients with type 2 diabetes who take sitagliptin and dapagliflozin together, in conjunction with diet and exercise therapy.
This medication can be administered to patients taking sitagliptin 100 mg and dapagliflozin 10 mg, at a dosage of 1 tablet once daily, regardless of meals. The tablet should be swallowed whole.
This medication may cause severe allergic reactions due to the sitagliptin component; if symptoms such as skin rash or difficulty breathing occur within 3 months of administration, discontinue use immediately and consult a physician. There is a risk of acute pancreatitis; inform medical staff immediately if there are severe abdominal pain or vomiting. This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or those on dialysis. Patients with impaired kidney function or depleted fluid volume may experience a decrease in blood pressure or worsening kidney function when using this medication; therefore, kidney function and fluid status should be monitored periodically before and during administration. As this medication lowers blood sugar, the risk of hypoglycemia may increase when used with insulin or sulfonylureas, and dosage adjustments may be necessary. This medication may increase the risk of genital infections and urinary tract infections; if infection symptoms occur, immediate treatment is required, and patients with a history of infections should be particularly cautious. Elderly patients or those with impaired liver function may be more affected by this medication, so careful monitoring during use is necessary. Pregnant or breastfeeding women should avoid using this medication and discontinue it immediately if pregnancy is confirmed. This medication does not significantly affect driving or operating machinery, but caution is required as hypoglycemic symptoms may occur. There is no specific antidote for overdose; appropriate treatment based on symptoms should be provided, and dialysis may be considered in severe cases. The safety and efficacy of this medication in children have not been established, so it is recommended not to use it. During treatment, be vigilant for adverse symptoms like fluid volume depletion, hypotension, ketoacidosis, and deterioration of kidney function, and consult medical staff immediately if such symptoms occur.
Urticaria, severe swelling (edema), anaphylaxis, angioedema, Stevens-Johnson syndrome, severe allergic reactions, severe rash with high fever, blisters, skin peeling, painful mucous membranes in the mouth/eyes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, respiratory issues, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should ideally be between 1 and 30 degrees Celsius.
Yellow to orange, double-sided, convex round film-coated tablets
Box) 28 tablets/box (7 tablets/(Alu-Alu) x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Albogent Korea Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.